Contact this trialFirst, we need to learn more about you.
Antiandrogen
HC-1119 vs Enzalutamide for Advanced Prostate Cancer
Recruiting2 awardsPhase 3
Washington, District of Columbia
This trial is a study to compare the effectiveness and safety of a new oral medication, HC-1119, to a current standard of care medication, enzalutamide, in men with asymptomatic or mildly symptomatic prostate cancer that has progressed despite treatment with prior hormone therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.